MA53508A - Cristal de pyrazolo[3,4-d]pyrimidine - Google Patents

Cristal de pyrazolo[3,4-d]pyrimidine

Info

Publication number
MA53508A
MA53508A MA053508A MA53508A MA53508A MA 53508 A MA53508 A MA 53508A MA 053508 A MA053508 A MA 053508A MA 53508 A MA53508 A MA 53508A MA 53508 A MA53508 A MA 53508A
Authority
MA
Morocco
Prior art keywords
pyrazolo
pyrimidine
crystal
pyrimidine crystal
Prior art date
Application number
MA053508A
Other languages
English (en)
Inventor
Hiromi Oshiumi
Tadashi Shimamura
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA53508A publication Critical patent/MA53508A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA053508A 2018-08-29 2019-08-28 Cristal de pyrazolo[3,4-d]pyrimidine MA53508A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018159840 2018-08-29

Publications (1)

Publication Number Publication Date
MA53508A true MA53508A (fr) 2022-05-11

Family

ID=69644316

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053508A MA53508A (fr) 2018-08-29 2019-08-28 Cristal de pyrazolo[3,4-d]pyrimidine

Country Status (6)

Country Link
US (1) US20210332056A1 (fr)
EP (1) EP3845537A4 (fr)
JP (1) JP7282787B2 (fr)
CN (1) CN112638914A (fr)
MA (1) MA53508A (fr)
WO (1) WO2020045475A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6141568B1 (ja) * 2015-09-01 2017-06-07 大鵬薬品工業株式会社 新規なピラゾロ［３，４−ｄ］ピリミジン化合物又はその塩

Also Published As

Publication number Publication date
WO2020045475A1 (fr) 2020-03-05
EP3845537A4 (fr) 2022-05-11
EP3845537A1 (fr) 2021-07-07
JP7282787B2 (ja) 2023-05-29
JPWO2020045475A1 (ja) 2021-08-10
US20210332056A1 (en) 2021-10-28
CN112638914A (zh) 2021-04-09

Similar Documents

Publication Publication Date Title
HK1257146A1 (zh) 新型的吡唑並[3，4-d]嘧啶化合物或其鹽
IL276802A (en) Transduced 2,1-dihydro-3h-pyrazolo[4,3-d]pyrimidin-3-ones
ES2980537T3 (es) Análogos de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona
DK3800189T3 (da) Fremstilling af (s)-n-(5-((r)-2-(2,5-difluorphenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidin-1-carboxamid
DK3419978T3 (da) Pyrazolo[1,5-A]pyrazin-4-yl-derivater som JAK-hæmmere
DK3400225T3 (da) Pentansyrederivater substitueret med pyrrolo-[2,3-b]pyrimidinpyridiner til behandling af influenzavirusinfektioner
IL262673A (en) A pyrazolo[5,1-a]pyrimidine compound
DK3737684T3 (da) 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-on-derivater og relaterede forbindelser som c5a-receptormodulatorer til behandling af vaskulitis og inflammatoriske sygdomme
MA46690A (fr) Composés de [1,2,4]triazolo [1,5-a]pyrimidine en tant qu'inhibiteurs de pde2
IL262711B1 (en) History of a [3,2,1]triazolo[5,4-d]pyrimidine with affinity for the type 2 cannabinoid receptor
DK3596080T3 (da) Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater
ES2981798T3 (es) Derivados de pirrolo[1,2-b] piridazina
DK3459953T3 (da) Hidtil ukendt 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-on-derivat
DK3362453T3 (da) Cykliske etherderivater af pyrazolo[1,5-a]pyrimidin-3-carboxyamid
DK3511333T3 (da) Krystalform og saltform af 7h-pyrrolo[2,3-d]pyrimidinforbindelse og fremgangsmåde til fremstilling deraf
MA54960A (fr) Dérivé de 7h-pyrrolo [2,3-d] pyrimidine-4-amine
MA53508A (fr) Cristal de pyrazolo[3,4-d]pyrimidine
EP3590516A4 (fr) Activateur d'effet antitumoral utilisant un composé pyrazolo[3,4-d]pyrimidine
ZA201902828B (en) Crystal of pyrido[3, 4-d]pyrimidine derivative or solvate thereof
IL253427A0 (en) The result of pyrazolo[3,4-d]pyrimidine and its use in the treatment of Jericho rose
GB201910656D0 (en) New use of triazolo(4,5-d)Pyrimidine deerivatives
HUE050298T2 (hu) Pirazolo[3,4-D]pirimidin vegyületek vagy annak sói
TH174289B (th) เกลือชนิดใหม่ของสารประกอบฟิวส์ไพริมิดีน และผลึกของมัน
TH1601001194A (th) อนุพันธ์ไตรอะโซโล[4,5-d]ไพริมิดีน ใหม่